JHX vs SOLS

JHX presents a stark contrast between deterministic value and growth expectations, with a Piotroski F-Score of 4/9 indicating stable but mediocre financial health and a Graham Number of $7.72 suggesting the stock is significantly overvalued. While revenue growth is robust at 30.10%, earnings have collapsed by 64.10% YoY, leading to an unsustainable trailing P/E of 90.79. The market is currently pricing in a massive recovery, as evidenced by the Forward P/E of 17.45 and a PEG ratio of 0.97. Despite strong analyst buy recommendations, the technical trend is bearish and the intrinsic value is severely disconnected from the current price.

SOLS exhibits a severe valuation disconnect, trading at $81.20 despite a Graham Number of $17.26 and an Intrinsic Value of $10.43. While the Piotroski F-Score of 5/9 indicates stable financial health, this is overshadowed by a catastrophic -69.3% collapse in earnings growth and a bearish technical trend (10/100). The company's high Debt/Equity ratio (1.84) and weak Quick Ratio (0.69) suggest liquidity risks that are not reflected in the current analyst 'Buy' consensus. Overall, the stock appears significantly overvalued relative to its fundamental performance and growth trajectory.